Hbk Investments L P Ascendis Pharma A/S Transaction History

Hbk Investments L P

  • $5.14 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$62.15 - $129.99 $8,638 - $18,068
-139 Reduced 1.94%
7,035 $828,000
Q3 2018

Nov 14, 2018
SELL
$63.77 - $76.28 $1.77 Million - $2.12 Million
-27,826 Reduced 79.5%
7,174 $508,000
Q3 2017

Nov 14, 2017
BUY
$26.89 - $37.1 $941,150 - $1.3 Million
35,000
35,000 $1.27 Million

Others Institutions Holding ASND

# of Institutions
240
Shares Held
58.3M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $6.98B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email